White & Case has expanded its competition practice in Australia with the recruitment of a former Allen & Overy lawyer to the firm’s Sydney office.
Two law firms that filed competing class actions against regenerative medicine company Mesoblast for allegedly misleading shareholders about its Remestemcel-L treatment for COVID-19 complications have agreed to join forces and sidestep a beauty parade.
The Albanese government will launch an inquiry into former prime minister Scott Morrison’s secret ministerial appointments after releasing a report by the Solicitor General, which found the appointments legally valid but “inconsistent” with the practices of responsible government.
Independent news publisher Crikey says it is calling Lachlan Murdoch’s bluff, splashing over its front page correspondence between its lawyers and an attorney acting for the Fox News CEO, who claims an article over the fatal January 6 riots on the US Capitol was defamatory.
Fighting what they say is a stultifying $1.23 million order for security for defence costs in a class action, franchisees of Hog’s Breath Cafe have argued it is up to the restaurant chain to prove group members can pony up the dough.
A New South Wales developer and construction company have been hit with a class action by aggrieved property owners at a Central Coast commercial development who say the building was riddled with defects, including subpar air conditioning.
AMP has admitted ASIC’s allegations that it acted unconscionably in charging life insurance premiums and advice fees to deceased customers, but the wealth manager will go head to head with the regulator over how much it should pay for its contraventions.
US animal health giant Zoetis has offered to shed assets to win competition clearance for its proposed takeover of NSW-based pet drug maker Jurox.
Law firm Johnson Winter & Slattery is expanding its footprint with the opening of a Canberra office spearheaded by two new partners lured from MinterEllison and leading M&A partner Marcus Clark.
Insurance Australia Group faces a class action by shareholders over its disclosures connected to the impact of COVID-19 claims by policyholders.